BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23260012)

  • 41. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.
    Bignell GR; Santarius T; Pole JC; Butler AP; Perry J; Pleasance E; Greenman C; Menzies A; Taylor S; Edkins S; Campbell P; Quail M; Plumb B; Matthews L; McLay K; Edwards PA; Rogers J; Wooster R; Futreal PA; Stratton MR
    Genome Res; 2007 Sep; 17(9):1296-303. PubMed ID: 17675364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
    Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
    Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.
    Lin E; Li L; Guan Y; Soriano R; Rivers CS; Mohan S; Pandita A; Tang J; Modrusan Z
    Mol Cancer Res; 2009 Sep; 7(9):1466-76. PubMed ID: 19737969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heterogeneous breakpoints on the immunoglobulin genes are involved in fusion with the 5' region of BCL2 in B-cell tumors.
    Yonetani N; Ueda C; Akasaka T; Nishikori M; Uchiyama T; Ohno H
    Jpn J Cancer Res; 2001 Sep; 92(9):933-40. PubMed ID: 11572760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
    Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
    BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.
    Zhao Q; Caballero OL; Levy S; Stevenson BJ; Iseli C; de Souza SJ; Galante PA; Busam D; Leversha MA; Chadalavada K; Rogers YH; Venter JC; Simpson AJ; Strausberg RL
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1886-91. PubMed ID: 19181860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
    Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA
    Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA; Cochran C; Marks JR; Iglehart JD; Zimmerman W; Barrett JC; Wiseman RW
    Cancer Res; 1994 Apr; 54(7):1791-4. PubMed ID: 7511052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relative timing of mutations in a breast cancer genome.
    Newman S; Howarth KD; Greenman CD; Bignell GR; Tavaré S; Edwards PA
    PLoS One; 2013; 8(6):e64991. PubMed ID: 23762276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
    Huang HE; Chin SF; Ginestier C; Bardou VJ; Adélaïde J; Iyer NG; Garcia MJ; Pole JC; Callagy GM; Hewitt SM; Gullick WJ; Jacquemier J; Caldas C; Chaffanet M; Birnbaum D; Edwards PA
    Cancer Res; 2004 Oct; 64(19):6840-4. PubMed ID: 15466169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive genome sequence analysis of a breast cancer amplicon.
    Collins C; Volik S; Kowbel D; Ginzinger D; Ylstra B; Cloutier T; Hawkins T; Predki P; Martin C; Wernick M; Kuo WL; Alberts A; Gray JW
    Genome Res; 2001 Jun; 11(6):1034-42. PubMed ID: 11381030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive copy number profiles of breast cancer cell model genomes.
    Shadeo A; Lam WL
    Breast Cancer Res; 2006; 8(1):R9. PubMed ID: 16417655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
    Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mobile element insertions are frequent in oesophageal adenocarcinomas and can mislead paired-end sequencing analysis.
    Paterson AL; Weaver JM; Eldridge MD; Tavaré S; Fitzgerald RC; Edwards PA;
    BMC Genomics; 2015 Jul; 16(1):473. PubMed ID: 26159513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization of ring chromosome 18 by low-coverage next generation sequencing.
    Ji X; Liang D; Sun R; Liu C; Ma D; Wang Y; Hu P; Xu Z
    BMC Med Genet; 2015 Jul; 16():57. PubMed ID: 26224010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High frequency of common DNA copy number abnormalities detected by bacterial artificial chromosome array comparative genomic hybridization in 24 breast cancer cell lines.
    Saito S; Morita K; Hirano T
    Hum Cell; 2009 Feb; 22(1):1-10. PubMed ID: 19222606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
    Lee S; Hu Y; Loo SK; Tan Y; Bhargava R; Lewis MT; Wang XS
    Proc Natl Acad Sci U S A; 2020 May; 117(18):9912-9921. PubMed ID: 32321829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing.
    McPherson A; Wu C; Wyatt AW; Shah S; Collins C; Sahinalp SC
    Genome Res; 2012 Nov; 22(11):2250-61. PubMed ID: 22745232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer.
    Johnson N; Speirs V; Curtin NJ; Hall AG
    Breast Cancer Res Treat; 2008 Sep; 111(1):55-63. PubMed ID: 17899364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.